Astrocytes are one of three types of glial cells in the central nervous system (CNS), comprising nearly 50% of non-neuronal CNS cells. The most diverse glial cell phenotypically, they play a key role in maintaining and supporting tissue homeostasis neuronal structure, energy metabolism, trophic factor delivery, synaptic transmission, long-distance communication, and inflammation. These cells proliferate throughout the entire lifespan of an individual, even during aging, which makes them an incredible therapeutic target for multiple CNS diseases. Despite their cryoprotective role, astrocytes can also be cytotoxic, depending on their activation phenotype, and the proteins they express are directly related to their functional state. In this article, we outline the protein markers of astrocytes as documented in recent literature.

Figure: This diagram highlights general markers for astrocytes.Structural Proteins
Astrocytes are complex cells morphologically, consisting of soma and processes, which form intricate branching processes. These branching processes facilitate cell-cell, cell-synapse, and cell-blood vessel communication throughout the CNS. Immature astrocytes express several structural proteins that play a critical role in astrocyte differentiation and formation of branching processes, including the intermediate filament proteins VIM, nestin, and synemin; however, these proteins are also expressed by other CNS cell types, including Bergmann glia. Thrombospondins, secreted glycoproteins that are also expressed in immature astrocytes, support normal synaptic structure.
Actin-related processes play a critical role in forming and supporting the complex branching structures found in mature astrocytes, and encompass several structural proteins that are enriched in astrocytes: CNN1, FMN2, NEBL, PDZ, PDLIM7, and SYNPO2. Additional structural markers of fine, peripheral astrocyte processes include ezrin and radixin.
One of the foundational three astrocyte marker proteins, GFAP plays a critical mechanical role in supporting astrocyte structure and the blood-brain barrier. While GFAP labels mainly the extensive branches of white matter astrocytes, making it the best marker for studying astrocyte morphology, it is expressed by other cell types, including neuronal stem cells.
Transcription Factors
Transcription factors also play a critical role in astrocyte differentiation, structure, and function, and they generally have proven more specific to astrocytes than commonly used structural protein markers. NKX2-1, a NK homeobox gene-coded protein, regulates GFAP expression and stem cell division. Two other NK homeobox gene-coded proteins, NKX3-1 and NKX6-1, are exclusively expressed by olfactory bulb and brainstem astrocytes, respectively. The nuclear transcription factor SOX9 is almost exclusive to astrocytes, and has been used as a reliable marker of astrocytes in the adult brain (outside neurogenic zones).
Antibodies Search Tool Search Now Search our directory to find the right antibodies for your research needs.
One of the first transcription factors used as a marker of astrocytes is the nuclear factor 1 (NF1) family member NF1A, which maintains astrocyte-synapse supporting functions in the hippocampus. Other NF1 family members expressed by astrocytes include NF1B and NF1X, which are present in the olfactory bulb, hippocampus, and cortex, and co-localize with ALDH1L1, a marker of astrocyte metabolism, in the brainstem. ALDH1L1, along with GFAP and S100β, is one of the classic astrocyte markers, and is the most selective of the three.
Membrane Proteins
Astrocytes support and maintain ion and energy homeostasis through several transmembrane channels and transporter proteins, many of which are specific to astrocytes. Gap junction channels are formed by a group of proteins called connexins. Cx26, Cx30, Cx40, and Cx43 support exchange with the extracellular milieu in addition to protein interactions, cell adhesion, and intracellular signaling. AQP4 supports water homeostasis, although it is not specific to astrocytes, expressed also in ependymal cells and Bergmann glia.
KIR 4.1 is responsible for potassium uptake from synaptic clefts by astrocytes, and BEST1 facilitates calcium-dependent transport of chloride ions. Glutamate-glutamine shuttle is an astrocyte-specific function, facilitated in part by sodium dependent glutamate transporters EAAT1 and EAAT2 (GLAST and GLT1 in rodents). ASCA-1 is a human and rodent-reactive antibody that specifically detects EAAT1/GLAST and labels all astrocytes positive for GFAP, GS, BLBP, RC2, and Nestin. While these markers are abundant in fine astrocyte processes, they are expressed by all other CNS cell types to a variable extent, and they are purported to play a key role in the development of neurological disorders.
Astrocytes also facilitate GABA transport, mainly at synapses, through GAT-3, an astrocyte-specific GABA transporter. GAT-1 is also expressed by astrocytes, but is less specific than GAT-3, as most GAT-1 is found in neurons. CD49f, a transmembrane protein that interacts with extracellular matrices, is another astrocyte-specific marker that can sort astrocytes from neurons and oligodendrocytes.
Metabolic Markers
Located in the cytoplasm of gray matter astrocytes, S100β is another of the three classical astrocytes markers. Composed of multiple isoforms, S100 proteins are calcium-binding proteins that play a number of physiological roles, including regulating calcium balance, energy homeostasis, and inflammation. S100β is specific to astrocytes.
Astrocytes are the only glial cells that store glucose, which they do by synthesizing glycogen via glycogen synthase (GS). Astrocytes utilize the glucose they’ve stored through glycogen phosphorylase (GP). Astrocytes can even facilitate glucose synthesis in the brain during periods of starvation by gluconeogenesis using glucose 6-phosphatase (G6PC) and fructose 1,6-bisphosphate (FBP). And because astrocytes exhibit a higher glycolytic rate than neurons under normal conditions, PFKFB3 and PFK are excellent astrocyte-enriched markers. Additional proteins involved in glycolysis that are either enriched in or specific to astrocytes include PKM2, PDK4, LDH5, and MCT4. PC and MCT1 are also expressed by astrocytes during glycolysis, but they are less specific markers as they are additionally expressed by other glial cells.
Fatty acid oxidation and glycogenic amino acid catabolism occur at much higher rates in astrocytes than in neurons. ABHD5, GK, GPAT3, and IDI1 all contribute to membrane lipid metabolism, while CTP1a and CTP2 are astrocyte-specific markers that transport long-chain fatty acids into mitochondria. FABP7, which binds both saturated and unsaturated long-chain fatty acids, is enriched in astrocytes filled with cytoplasmic granules believed to originate from damaged mitochondria, but is also expressed in neural stem cells throughout development. Acetyl-coA from fatty acid oxidation is further transformed into acetoacetate in astrocytes via HMGCS2. GLDC, GPT2, HIBADH, SERHL, SDSL, PRODH, and 3PGDH are proteins involved in amino acid catabolism and are enriched in astrocytes. Fatty acid oxidation in astrocytes is regulated by T3, which is produced from T4 by DIO2 and aided by HADHA, most of which co-localizes with GFAP. T4 is produced by upstream astrocytic thyroid hormone metabolism, which is mediated by SLCO1C1/OATP1C1.
Cholesterol, required for axonal growth and synaptogenesis, is synthesized by astrocytes via SCAP and HMGCR sequentially. APOE and ABCA7 are cholesterol transporters, and their transcription is controlled by LXR/RXR. Astrocytes also facilitate glutamate uptake and recycling at synapses via astrocyte-specific enzyme GLUL and the amino acid transporters SNAT3 and SNAT5. Some of this glutamate is transported to the mitochondria by GC-2, which is enriched in astrocytes but also expressed by oligodendrocyte progenitor cells, and is then deaminated by GDH.
Table of Astrocyte Markers
The table below lists human and rodent protein markers of astrocytes as described by recent literature. The proteins listed include both general and specific astrocyte markers, and comprise the major groups of astrocyte markers: structural proteins, transcription factors, transmembrane proteins, and metabolic markers. Accompanying each marker are links to relevant antibodies and ELISA kits, as these immunodetection tools are routinely used in cell characterization studies via flow cytometry and immunostaining. The associated products are offered by a variety of manufacturers and can serve as a useful reference for astrocyte immunophenotyping.
| Gene | Synonyms | Marker Type | Protein Type | Localization | Size (kDa) | Reference | Antibodies | ELISA Kits |
| ABCA7 |
- |
Astrocytes, Neurons, and Microglia |
Transporter |
Cytoplasmic and Membrane |
234.4 |
1 |
ABCA7 antibodies |
ABCA7 ELISA |
| ABHD5 |
- |
General Astrocyte Marker |
Enzyme |
Cytoplasmic |
39.1 |
1 |
ABHD5 antibodies |
ABHD5 ELISA |
| ALDH1L1 |
- |
General Astrocyte Marker |
Enzyme |
Cytoplasmic |
98.8 |
1,2,4,5 |
ALDH1L1 antibodies |
ALDH1L1 ELISA |
| APOE |
- |
Astrocyte Endfeet, Microglia, Neurons |
Lipoprotein |
Secreted |
36.2 |
1,4 |
APOE antibodies |
APOE ELISA |
| AQP4 |
- |
Astrocyte Endfeet |
Transporter |
Membrane |
34.8 |
1,3,5,7 |
AQP4 antibodies |
AQP4 ELISA |
| BEST1 |
- |
Cortical and Hippocampal Astrocytes |
Ion Channel |
Membrane |
67.7 |
1 |
BEST1 antibodies |
BEST1 ELISA |
| CNN1 |
calponin 1 |
Mature Astrocytes |
Binding Protein |
Cytoplasmic |
33.2 |
1 |
Calponin 1 antibodies |
Calponin 1 ELISA |
| CPT1A |
- |
General Astrocyte Marker |
Enzyme |
Mitochondrial |
88.4 |
1 |
CPT1A antibodies |
CPT1A ELISA |
| CPT2 |
- |
General Astrocyte Marker |
Enzyme |
Mitochondrial |
73.8 |
1 |
CPT2 antibodies |
CPT2 ELISA |
| DIO2 |
- |
Enriched in Astrocytes, also expressed by Radial Glia |
Enzyme |
Membrane |
30.6 |
1,5 |
DIO2 antibodies |
DIO2 ELISA |
| EZR |
ezrin |
Fine Astrocyte Processes |
Binding Protein |
Cytoplasmic and Membrane |
69.4 |
1 |
Ezrin antibodies |
Ezrin ELISA |
| FABP7 |
- |
Astrocytes rich in cytoplasmic granules |
Binding Protein |
Cytoplasmic |
14.9 |
1 |
FABP7 antibodies |
FABP7 ELISA |
| FBP1 |
FBPase |
Selective for Astrocytes |
Enzyme |
Cytoplasmic, Nuclear |
36.8 |
1 |
FBP1 antibodies |
FBP1 ELISA |
| FMN2 |
Formin 2 |
Mature Astrocytes |
Binding Protein |
Nuclear, Cytoplasmic and Membrane |
180.1 |
1 |
Formin 2 antibodies |
Formin 2 ELISA |
| G6PC1 |
G6PC |
Selective for Astrocytes |
Enzyme |
Endoplasmic Reticulum |
40.5 |
1, 2 |
G6PC1 antibodies |
G6PC1 ELISA |
| GFAP |
- |
Classic Astrocyte Marker, White Matter Astrocytes |
Cytoskeletal Protein |
Cytoplasmic |
49.9 |
1-3, 5,7 |
GFAP antibodies |
GFAP ELISA |
| GJA1 |
Cx43 |
Astrocyte Endfeet |
Gap Junction Protein |
Membrane |
43 |
1,7 |
GJA1 antibodies |
GJA1 ELISA |
| GJA5 |
Cx40 |
General Astrocyte Marker |
Gap Junction Protein |
Membrane |
40.4 |
7 |
GJA5 antibodies |
GJA5 ELISA |
| GJB2 |
Cx26 |
General Astrocyte Marker |
Gap Junction Protein |
Membrane |
26.2 |
1 |
GJB2 antibodies |
GJB2 ELISA |
| GJB6 |
Cx30 |
Mature Astrocytes |
Gap Junction Protein |
Membrane |
30.4 |
1 |
GJB6 antibodies |
GJB6 ELISA |
| GK |
- |
General Astrocyte Marker |
Enzyme |
Cytoplasmic and Mitochondrial |
61.2 |
1 |
GK antibodies |
GK ELISA |
| GLDC |
- |
General Astrocyte Marker |
Enzyme |
Mitochondrial |
112.7 |
1 |
GLDC antibodies |
GLDC ELISA |
| GLUD1 |
GDH |
General Astrocyte Marker |
Enzyme |
Mitochondrial |
61.4 |
1 |
GLUD1 antibodies |
GLUD1 ELISA |
| GLUL |
- |
Selective for Astrocytes |
Enzyme |
Cytoplasmic, Mitochondrial and Membrane |
42.1 |
1 |
GLUL antibodies |
GLUL ELISA |
| GP* |
- |
General Astrocyte Marker |
Enzyme |
Membrane |
37.9 |
1 |
GPNMB antibodies |
GPNMB ELISA |
| GPAT3 |
- |
Astrocytes; Oligodendrocyte precursors |
Enzyme |
Endoplasmic Reticulum |
48.7 |
1 |
GPAT3 antibodies |
GPAT3 ELISA |
| GPT2 |
- |
Enriched in Astrocytes |
Enzyme |
Mitochondrial |
57.9 |
1 |
GPT2 antibodies |
GPT2 ELISA |
| GYS1 |
GS |
Selective for Astrocytes |
Enzyme |
Cytoplasmic |
83.8 |
1,2,7 |
GYS1 antibodies |
GYS1 ELISA |
| HADHA |
- |
Astrocytes, co-localizes with GFAP |
Enzyme |
Mitochondrial |
83 |
1 |
HADHA antibodies |
HADHA ELISA |
| HIBADH |
- |
Enriched in Astrocytes |
Enzyme |
Mitochondrial |
35.3 |
1 |
HIBADH antibodies |
HIBADH ELISA |
| HMGCR |
- |
Astrocytes, Neurons |
Enzyme |
Endoplasmic Reticulum |
97.5 |
1 |
HMGCR antibodies |
HMGCR ELISA |
| HMGCS2 |
- |
Selective for Astrocytes |
Enzyme |
Mitochondrial |
56.6 |
1 |
HMGCS2 antibodies |
HMGCS2 ELISA |
| IDI1 |
- |
Astrocytes, Oligodendrocyte precursors |
Enzyme |
Peroxisome |
26.3 |
1 |
IDI1 antibodies |
IDI1 ELISA |
| ITGA6 |
CD49f |
Fetal and Mature Astrocytes, Neurons, Oligodendrocytes |
Receptor |
Membrane |
126.6 |
3 |
ITGA6 antibodies |
ITGA6 ELISA |
| ITGB5 |
- |
Immature and Mature Astrocytes, Mouse Marker |
Receptor |
Membrane |
- |
3,4 |
ITGB5 antibodies |
ITGB5 ELISA |
| KCNJ10 |
KIR4.1 |
Gray Matter Astrocytes |
Ion Channel |
Membrane |
42.5 |
1 |
KCNJ10 antibodies |
KCNJ10 ELISA |
| LDHA |
LDH5 |
Enriched in Astrocytes |
Enzyme |
Cytoplasmic |
36.7 |
1 |
LDHA antibodies |
LDHA ELISA |
| LXR/RXR |
- |
General Astrocyte Marker |
Transcription Factor, Multi-Subunit |
Nuclear |
- |
1 |
LXR antibodies |
LXR ELISA |
| NEBL |
nebulette |
Mature Astrocyte |
Cytoskeletal Protein |
Cytoplasmic |
116.5 |
1 |
nebulette antibodies |
nebulette ELISA |
| NES |
nestin |
Immature Astrocytes; Stem/Progenitor Cells |
Cytoskeletal Protein |
Cytoplasmic |
177.4 |
1 |
nestin antibodies |
nestin ELISA |
| NFIA |
NF1A |
Selective for Astrocytes |
Transcription Factor |
Nuclear |
55.9 |
1,3 |
NFIA antibodies |
NFIA ELISA |
| NFIB |
NF1B |
Astrocytes in the Hippocampus, Cortex, and Brainstem |
Transcription Factor |
Nuclear |
47.4 |
1 |
NFIB antibodies |
NFIB ELISA |
| NFIX |
NF1X |
Astrocytes in the Olfactory Bulb, Hippocampus, Brainstem, and Cortex |
Transcription Factor |
Nuclear |
55.1 |
1 |
NFIX antibodies |
NFIX ELISA |
| NKX2-1 |
- |
Telencephalic Astrocytes |
Transcription Factor |
Nuclear |
38.6 |
1 |
NKX2-1 antibodies |
NKX2-1 ELISA |
| NKX3-1 |
- |
Olfactory Bulb Astrocytes |
Transcription Factor |
Nuclear |
26.4 |
1 |
NKX31 antibodies |
NKX31 ELISA |
| NKX6-1 |
- |
Brainstem Astrocytes |
Transcription Factor |
Nuclear |
37.8 |
1 |
NKX61 antibodies |
NKX61 ELISA |
| PC |
- |
General Astrocyte Marker |
Enzyme |
Mitochondrial |
129.6 |
1 |
PC antibodies |
PC ELISA |
| PDK4 |
- |
Enriched in Astrocytes; also in Microglial cells |
Enzyme |
Mitochondrial |
46.5 |
1 |
PDK4 antibodies |
PDK4 ELISA |
| PDLIM7 |
- |
Mature Astrocytes |
Cytoskeletal Protein |
Cytoplasmic |
49.8 |
1 |
PDLIM7 antibodies |
PDLIM7 ELISA |
| PDZK1 |
PDZ |
Mature Astrocytes |
Scaffold Protein |
Membrane |
57.1 |
1 |
PDZK1 antibodies |
PDZK1 ELISA |
| PFK* |
- |
Astrocytes, Neurons |
Enzyme |
Cytoplasmic |
85.2 |
1 |
PFK* antibodies |
PFK* ELISA |
| PFKFB3 |
- |
Enriched in Astrocytes |
Enzyme |
Cytoplasmic, Nuclear |
59.6 |
1 |
PFKFB3 antibodies |
PFKFB3 ELISA |
| PHGDH |
3PGDH |
General Astrocyte Marker |
Enzyme |
Cytoplasmic |
56.7 |
1 |
PHGDH antibodies |
PHGDH ELISA |
| PKM |
PKM2 |
Enriched in Astrocytes, expressed by other Glial cells |
Enzyme |
Nuclear and Cytoplasmic |
57.9 |
1 |
PKM antibodies |
PKM ELISA |
| PRODH |
- |
Enriched in Astrocytes |
Enzyme |
Mitochondrial |
68 |
1 |
PRODH antibodies |
PRODH ELISA |
| RDX |
radixin |
Fine Astrocyte Processes |
Binding Protein |
Cytoplasmic and Membrane |
68.6 |
1 |
radixin antibodies |
radixin ELISA |
| S100B |
S100β |
Gray Matter Astrocytes |
Binding Protein |
Nuclear and Cytoplasmic |
10.7 |
1-3,5,7 |
S100B antibodies |
S100B ELISA |
| SCAP |
- |
Astrocytes, Oligodendrocytes |
Binding Protein |
Endoplasmic Reticulum |
139.7 |
1 |
SCAP antibodies |
SCAP ELISA |
| SDSL |
- |
Enriched in Astrocytes |
Enzyme |
Cytoplasmic |
34.7 |
1 |
SDSL antibodies |
SDSL ELISA |
| SERHL |
- |
Enriched in Astrocytes |
Enzyme |
Cytoplasmic |
22.5 |
1 |
SERHL antibodies |
SERHL ELISA |
| SLC16A1 |
MCT1 |
Age-Dependent Expression in Astrocytes, Oligodendrocytes |
Transporter |
Membrane |
53.9 |
1 |
SLC16A1 antibodies |
SLC16A1 ELISA |
| SLC16A3 |
MCT4 |
Selective for Astrocytes |
Transporter |
Membrane |
49.5 |
1 |
SLC16A3 antibodies |
SLC16A3 ELISA |
| SLC1A2 |
EAAT2, GLT1 |
Fine Astrocyte Processes |
Transporter |
Membrane |
62.1 |
1,5,7 |
SLC1A2 antibodies |
SLC1A2 ELISA |
| SLC1A3 |
EAAT1, GLAST, ASCA-1 |
Fine Astrocyte Processes |
Transporter |
Membrane |
59.6 |
1,3,7 |
SLC1A3 antibodies |
SLC1A3 ELISA |
| SLC25A18 |
GC-2 |
Protoplasmic Astrocytes; Oligodendrocyte Progenitor cells |
Transporter |
Mitochondrial |
33.8 |
1 |
SLC25A18 antibodies |
SLC25A18 ELISA |
| SLC2A1 |
GLUT1 |
Gray Matter Astrocytes |
Transporter |
Membrane |
54.1 |
1 |
SLC2A1 antibodies |
SLC2A1 ELISA |
| SLC38A3 |
SNAT3 |
Selective for Astrocytes |
Transporter |
Membrane |
55.8 |
1 |
SLC38A3 antibodies |
SLC38A3 ELISA |
| SLC38A5 |
SNAT5 |
Selective for Astrocytes |
Transporter |
Membrane |
51.5 |
1 |
SLC38A5 antibodies |
SLC38A5 ELISA |
| SLC6A1 |
GAT-1 |
Distal Astrocytic processes, but majority expressed in Neurons |
Transporter |
Membrane |
67.1 |
1 |
SLC6A1 antibodies |
SLC6A1 ELISA |
| SLC6A11 |
GAT-3 |
Selective for Astrocytes |
Transporter |
Membrane |
70.6 |
1 |
SLC6A11 antibodies |
SLC6A11 ELISA |
| SLCO1C1 |
OATP1C1 |
Astrocytes, Radial Glia |
Transporter |
Membrane |
78.7 |
1 |
SLCO1C1 antibodies |
SLCO1C1 ELISA |
| SOX9 |
- |
Reactive Astrocytes |
Transcription Factor |
Nuclear |
56.1 |
1,3 |
SOX9 antibodies |
SOX9 ELISA |
| SYNM |
synemin |
Immature Astrocytes |
Cytoskeletal Protein |
Cytoplasmic |
172.9 |
1 |
synemin antibodies |
synemin ELISA |
| SYNPO2 |
- |
Mature Astrocytes |
Cytoskeletal Protein |
Nuclear, Cytoplasmic |
117.5 |
1 |
SYNPO2 antibodies |
SYNPO2 ELISA |
| THBS1 |
TSP |
Immature Astrocytes |
Glycoprotein |
Secreted |
129.4 |
5,8 |
THBS1 antibodies |
THBS1 ELISA |
| VIM |
vimentin |
Immature Astrocytes in White Matter |
Cytoskeletal Protein |
Nuclear, Cytoplasmic and Membrane |
53.7 |
1,3,5 |
vimentin antibodies |
vimentin ELISA |
Note: *Some markers are protein isoforms, multi-subunit protein complexes, or protein families composed of several distinct genes. Information on Protein Type, Localization, and Size (kDa) obtained from UniProt.org (for human genes only).
References
1. Jurga AM, Paleczna M, Kadluczka J et al. Beyond the GFAP-Astrocyte Protein Markers in the Brain. Biomolecules. 2021; 11(9):1361. doi: 10.3390/biom11091361
2. Guillamón-Vivancos T, Gómez-Pinedo U, and Matías-Guiu J. Astrocytes in neurodegenerative diseases (I): function and molecular description. Neurologia. 2015; 30(2):119-129. doi: 10.1016/j.nrleng.2014.12.005 Neurologia. 2015; 30(2):119-129. doi: 10.1016/j.nrleng.2014.12.005
3. Barber L, Jain T, Zimmer M, et al. CD49f is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes. Neuron. 2020; 107 (3):436-453. doi: 10.1016/j.neuron.2020.05.014.
4. Foo LC, Allen NJ, Bushong EA, et al. Development of a Novel Method for the Purification and Culture of Rodent Astrocytes. Neuron. 2011; 71(5): 799-811. doi: 10.1016/j.neuron.2011.07.022
5. Katsel P, Byne W, Roussos P, et al. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology. 2011; 36(6):1171-7. doi: 10.1038/npp.2010.252
6. Jungblut M, Tiveron MC, Barral S, et al. Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-1. Glia. 2012;60(6):894-907. doi:10.1002/glia.22322
7. Rajkowska G and Stockmeier CA. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets. 2013; 14(11): 1225-36. doi: 10.2174/13894501113149990156
8. Christopherson KS, Ullian EM, Stokes CCA et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005; 120(3):421-33. doi: 10.1016/j.cell.2004.12.020